Molecular and pathological events involved in the pathogenesis of diabetes associated non-alcoholic fatty liver disease

Publication date: Available online 12 November 2018Source: Journal of Clinical and Experimental HepatologyAuthor(s): Onkar Bedi, Savera Aggarwal, Nirupma Trehanpati, Gayatri Ramakrishna, Pawan KrishanAbstractDiabetes mellitus is a rising epidemic in most part of the world and is often associated with multiple organ disorders such as kidney, liver and cardiovascular diseases. Liver is a major metabolic hub and the metabolic disorders associated with diabetes result in liver dysfunctions culminating in spectrum of liver diseases such as fatty liver disorders, cirrhosis and hepatocellular carcinoma. The intervention strategies to prevent diabetes associated liver injury require an overall understanding of the key factors and molecular pathways which can be strategically targeted. The present review focuses on some of the key aspects of fatty acid metabolism, fetuin-A regulation, inflammatory pathways and genetic factors associated with insulin resistance, dyslipidemia, hyperglycemia, oxidative stress etc. involved in nexus between diabetes and liver injury. Further recent interventions, pharmacological target and newer therapeutic agents are discussed briefly for the better clinical management of diabetes associated hepatic disorders.Graphical abstractIllustration of Linking between Free Fatty Acid with Diabetic Liver Injury [DIL: Diabetic Liver Injury; FFA: Free Fatty Acid; ROS: Reactive Oxygen Species; TNF: Tumor Necrosis Factor; IRS-1: Insulin receptor substrate 1; PI3K: Phos...
Source: Journal of Clinical and Experimental Hepatology - Category: Gastroenterology Source Type: research